Professor Peter Toth shares his insights on how to lower cardiovascular risk at the 4th World Congress of Lipidology in Vienna, Austria.

Video: https://medicaldigest.org/scientific-contents/interview:lower-better-never-mind-future-drugs-use-what-you-have-available-fullest-extent-and-lower-cardiovascular-risk-aggressively

Professor Karam Kostner shares his insights how to treat elevated Lp(a) at the 4th World Congress of Lipidology in Vienna, Austria?

Video: https://medicaldigest.org/scientific-contents/interview:how-treat-elevated-lp

Professor Martin Clodi shares his insights what clinicians must know about diabetic dyslipidemia at the 4th World Congress of Lipidology in Vienna, Austria.

Video: https://medicaldigest.org/scientific-contents/interview:what-clinicians-must-know-about-diabetic-dyslipidemia

Professor Gerald Watts shares his insights how to implement LDL guidelines at the 4th World Congress of Lipidology in Vienna, Austria.

Video: https://medicaldigest.org/scientific-contents/interview:how-implement-ldl-guidelines

Professor Caroline Bachmeier shares her insights on the rationale of small children and newborn screening for atherosclerosis at the 4th World Congress of Lipidology in Vienna, Austria.

Video: https://medicaldigest.org/scientific-contents/interview:newborn-screening-atherosclerosis-risk

Professor Maciej Banach shares his insights what will change in the lipid lowering landscape in the next 5 years at the 4th World Congress of Lipidology in Vienna, Austria.

Video: https://medicaldigest.org/scientific-contents/interview:what-will-change-lipid-lowering-landscape-next-5-years

Professor Gersina Rega Kaun shares her insights on lipid lowering in diabetics at the 4th World Congress of Lipidology in Vienna, Austria.

Video: https://medicaldigest.org/scientific-contents/interview:diabetic-dyslipidemia-beyond-ldl-atherogenic-lipoproteins-focus

Professor Dereck Connolly shares his insights on LDL lowering in 2025 at the 4th World Congress of Lipidology in Vienna, Austria.

Video: https://medicaldigest.org/scientific-contents/interview:ldl-lowering-2025-optimal-approach

Professor Matthew Matasar explains the highly anticipated results of the Phase III POLARGO trial after the 2025 EHA Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:polargo-trial-shows-os-benefit-pola-r-gemox-transplant-ineligible-rr-dlbcl

Professor Dennis Kim shares his insights on the asciminib in the treatment of chronic myeloid leukemia after the 2025 EHA Annual Meeting.

Video: https://medicaldigest.org/scientific-contents/interview:asciminib-treatment-cml